Optical Coherence Tomography (OCT) Data Collection Study
This study has been completed.
Sponsor:
Optovue
Information provided by (Responsible Party):
Optovue
ClinicalTrials.gov Identifier:
NCT01459731
First received: October 23, 2011
Last updated: May 1, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Collect OCT data to evaluate the range and age trend of eye measurements.
| Condition |
|---|
|
No Eye Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Optical Coherence Tomography Data Collection Study |
Resource links provided by NLM:
Further study details as provided by Optovue:
Primary Outcome Measures:
- range of eye measurements [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- age trend of eye measurements [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 400 |
| Study Start Date: | September 2011 |
| Study Completion Date: | March 2012 |
| Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Age 18-29 |
| Age 30-39 |
| Age 40-49 |
| Age 50-59 |
| Age 60-69 |
| Age 70+ |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
No eye disease
Criteria
Inclusion Criteria:
- At least 18 years of age
- Able and willing to provide consent
- Able and willing to complete the required examininations and visit
- Refractive error within 8 diopters sphere and within 2 diopters cylinder in each eye
- Best corrected visual acuity of 20/30 or better in each eye
Exclusion Criteria:
- History of leukemia, AIDS, dementia or multiple sclerosis
- Concomitant use of hydroxycloroquine or chloroquine
- Family history of glaucoma among first degree relatives
- Intraocular pressure of 22mm Hg or greater in either eye
- Unreliable or abnormal visual field
- Active ocular disease
- Previously diagnosed with glaucoma or glaucoma suspect
- Congenital ocular abnormalities
- Previous intra-ocular surgery or laser treatment (other than refractive surgery or uncomplicated cataract surgery greater than 6 months previously)
- Anatomic narrow angle
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01459731
Locations
| United States, California | |
| Southern California College of Optometry | |
| Fullerton, California, United States, 92831 | |
| College of Optometry, Western University of Health Sciences | |
| Pomona, California, United States, 91766 | |
| Buena Vista Eye Care | |
| San Jose, California, United States, 95112 | |
| United States, Illinois | |
| Illinois Eye Institute | |
| Chicago, Illinois, United States, 60616 | |
| United Kingdom | |
| Institute of Ophthalmology, University College London | |
| London, England, United Kingdom, EC1V 9EL | |
Sponsors and Collaborators
Optovue
Investigators
| Principal Investigator: | George Comer, OD, MBA | Southern California College of Optometry |
| Principal Investigator: | Michael Chaglasian, OD | Illinois Eye Institute |
| Principal Investigator: | Jorge Cuadros, OD, PhD | Buena Vista Eye Care |
| Principal Investigator: | David Garway-Heath, MD | Institute of Ophthalmology, University College London |
| Principal Investigator: | Pinakin G Davey, OD, PhD | Western University of Health Sciences |
More Information
No publications provided
| Responsible Party: | Optovue |
| ClinicalTrials.gov Identifier: | NCT01459731 History of Changes |
| Other Study ID Numbers: | OCT 200-47091 |
| Study First Received: | October 23, 2011 |
| Last Updated: | May 1, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Eye Diseases |
ClinicalTrials.gov processed this record on June 18, 2013